Your search returned 34 studies. (Get alerts for new studies):
- Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
Conditions: Steatohepatitis
Location: Dothan, Alabama
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
Conditions: Attention-deficit/Hyperactivity Disorder
Location: Dothan, Alabama
- Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Conditions: Tourette's Disorder
Location: Dothan, Alabama
- Growth and Tolerance of Hypoallergenic Formulas
Conditions: Growth of Term Infants
Location: Dothan, Alabama
- Gilead Sustained Virologic Response (SVR) Registry
Conditions: Hepatitis C, Chronic
Location: Dothan, Alabama
- A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Conditions: Hepatitis C, Chronic
Location: Dothan, Alabama
- Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Dothan, Alabama
- A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-267 and With and Without Ribavirin (RBV) in Treatment-Naïve Subjec
Conditions: Hepatitis C Virus
Location: Dothan, Alabama
- Safety and Efficacy of Vilazodone in Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Dothan, Alabama
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Dothan, Alabama
- Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM2)
Conditions: Bipolar Disorder
Location: Dothan, Alabama
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM2)
Conditions: Bipolar Disorder, Pediatric
Location: Dothan, Alabama
- OPT - Phase IV Long Term Maintenance Study of Aripiprazole for the Treatment of Irritability Associated With Autistic Disorder
Conditions: Autistic Disorder
Location: Dothan, Alabama
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children an
Conditions: Major Depressive Disorder
Location: Dothan, Alabama
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children an
Conditions: Major Depressive Disorder
Location: Dothan, Alabama
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Conditions: Major Depressive Disorder
Location: Dothan, Alabama
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Conditions: Major Depressive Disorder
Location: Dothan, Alabama
- Smoking Cessation Study In Healthy Adolescent Smokers
Conditions: Smoking Cessation
Location: Ozark, Alabama
- Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients
Conditions: Bipolar Disorder
Location: Dothan, Alabama
- Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
Conditions: Schizophrenia, Paranoid - Schizophrenia, Disorganized - Schizophrenia, Undifferentiated
Location: Dothan, Alabama
- Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897 AM2 EXT)
Conditions: Schizophrenia, Paranoid - Schizophrenia, Disorganized - Schizophrenia, Undifferentiated
Location: Dothan, Alabama
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Dothan, Alabama
- Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode
Conditions: Adolescent Schizophrenia - Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Location: Dothan, Alabama
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Dothan, Alabama
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Dothan, Alabama
- A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Conditions: Major Depressive Disorder
Location: Dothan, Alabama
- A Study in Pediatric Patients With Generalized Anxiety Disorder
Conditions: Anxiety Neuroses - Anxiety States, Neurotic - Neuroses, Anxiety
Location: Dothan, Alabama
- A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Conditions: Overactive Bladder
Location: DeFuniak Springs, Florida
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Defuniak Springs, Florida
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Defuniak Springs, Florida
- Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Conditions: Bipolar I Disorder
Location: Dothan, Alabama
- Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Location: DeFuniak Springs, Florida
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: DeFuniak Springs, Florida
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: DeFuniak Springs, Florida
|